Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20705060

Biochem. Pharmacol. 2010 Nov 15 80 10 1507-16

Download in:

View as

General Info

PMID
20705060